Early detection of molecular residual disease and risk stratification for stage I to III colorectal cancer via circulating tumor DNA methylation

S Mo, L Ye, D Wang, L Han, S Zhou, H Wang… - JAMA …, 2023 - jamanetwork.com
Importance Detection of molecular residual disease and risk stratification as early as
possible may improve the treatment of patients with cancer. Efficient pragmatic tests are …

Effect of incorporation of pretreatment serum carcinoembryonic antigen levels into AJCC staging for colon cancer on 5-year survival

P Thirunavukarasu, C Talati, S Munjal, K Attwood… - JAMA …, 2015 - jamanetwork.com
Importance The American Joint Committee on Cancer (AJCC) has proposed the inclusion of
pretreatment serum carcinoembryonic antigen (CEA) levels (C stage) into the conventional …

[HTML][HTML] Clinical implication of tissue carcinoembryonic antigen expression in association with serum carcinoembryonic antigen in colorectal cancer

AF Aldilaijan, YI Kim, CW Kim, YS Yoon, IJ Park… - Scientific reports, 2023 - nature.com
This study aimed to evaluate the prognostic significance of carcinoembryonic antigen (CEA)
expression in tumor tissues of patients with colorectal cancer (CRC). The cohort included …

A genome wide association study of genetic loci that influence tumour biomarkers cancer antigen 19-9, carcinoembryonic antigen and α fetoprotein and their …

M He, C Wu, J Xu, H Guo, H Yang, X Zhang, J Sun… - Gut, 2014 - gut.bmj.com
Objective Tumour biomarkers are used as indicators for cancer screening and as predictors
for therapeutic responses and prognoses in cancer patients. We aimed to identify genetic …

Preoperative carcinoembryonic antigen as a poor prognostic factor in stage I–III colorectal cancer after curative-intent resection: a propensity score matching analysis

SH Huang, WS Tsai, JF You, HY Hung, CY Yeh… - Annals of surgical …, 2019 - Springer
Background Preoperative carcinoembryonic antigen (CEA) has yet to be used as a
prognostic or adjuvant chemotherapy factor for colorectal cancer (CRC). Methods This …

Elevated preoperative carcinoembryonic antigen (CEA) and Ki67 is predictor of decreased survival in IIA stage colon cancer

Y Peng, L Wang, J Gu - World journal of surgery, 2013 - Springer
Background The present study was designed to investigate the prognostic factors of stage
IIA (pT3N0M0) colon cancer. Methods We retrospectively reviewed consecutive patients with …

New targets for the immunotherapy of colon cancer—does reactive disease hold the answer?

V Boncheva, SA Bonney, SE Brooks, M Tangney… - Cancer gene …, 2013 - nature.com
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers in both men and
women, posing a serious demographic and economic burden worldwide. In the United …

Preoperative carcinoembryonic antigen and prognosis of colorectal cancer. An independent prognostic factor still reliable

G Li Destri, AS Rubino, R Latino… - International …, 2015 - meridian.allenpress.com
To evaluate whether, in a sample of patients radically treated for colorectal carcinoma, the
preoperative determination of the carcinoembryonic antigen (p-CEA) may have a prognostic …

B7‐H3: A Useful Emerging Diagnostic Marker for Colon Cancer

O Bostanci, P Sayin, R Kiziltan, S Algul… - BioMed Research …, 2022 - Wiley Online Library
Background. Colon cancer is the second most common malignancy causing the majority of
cancer‐related deaths. B7‐H3 concentrations have drawn major interest as possible …

[HTML][HTML] CEA decline predicts tumor regression and prognosis in locally advanced rectal cancer patients with elevated baseline CEA

Z Cai, L Huang, Y Chen, X Xie, Y Zou, P Lan… - Journal of …, 2020 - ncbi.nlm.nih.gov
Purpose: To investigate the value of carcinoembryonic antigen (CEA) decline in predicting
pathological tumor regression and outcome for locally advanced rectal cancer (LARC) …